H.R.5750: Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014

About This Bill

Bill Summary

Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services (HHS) to extend by six months the exclusivity period for a drug or biological product approved by the Food and Drug Administration (FDA) when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 4 statements associated with H.R.5750.

Bill Actions

Date Description
Nov. 21, 2014
Referred to the Subcommittee on Health.
Nov. 20, 2014
Referred to the House Committee on Energy and Commerce.
Nov. 20, 2014

Introduced in the House by Gus Bilirakis (R-Fla.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page